Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 3:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 3001–3024 of 7,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Control Clear all

Conditions: Leukemia
Interventions: Quizartinib, Placebo, Chemotherapy; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 52
States / cities: Goodyear, Arizona • Phoenix, Arizona • Tucson, Arizona + 43 more

Conditions: Asthma, Asthma in Children
Interventions: Hospital to Home Transition (H2H); Behavioral
Lead sponsor: Kavita Parikh; Other
Eligibility: 4 Years to 12 Years
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Cancer, Obesity, Lifestyle, Sedentary, Physical Activity, Health Behavior, Chronic Disease, Diet Modification
Interventions: Community Garden Intervention; Behavioral
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 18 Years and older
Enrollment: 296 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Nausea and Vomiting, Nausea, Vomiting
Interventions: Fosaprepitant for Injection, Metoclopramide Injection; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: COVID, COVID-19, SARS-CoV-2, SARS (Severe Acute Respiratory Syndrome)
Interventions: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG), Placebo, Remdesivir; Biological · Other · Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 593 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 18
States / cities: Colorado Springs, Colorado • Lakewood, Colorado • Westminster, Colorado + 13 more

Conditions: Borderline Resectable Pancreatic Ductal Adenocarcinoma
Interventions: Biospecimen Collection, Computed Tomography, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Fluorouracil, Gadolinium-Chelate, Gemcitabine, Irinotecan, Leucovorin Calcium, Nab-paclitaxel, Oxaliplatin, Point-of-care portable perfusion phantom (P4); Procedure · Drug · Device
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Suicide, Substance-Related Disorders
Interventions: Preventing Addiction Related Suicide (PARS), Intensive Outpatient Program standard session; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 906 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 16
States / cities: Auburn, Washington • Edmonds, Washington • Everett, Washington + 9 more

Conditions: Malignant Head and Neck Neoplasm, Mucositis, Radiation-Induced Disorder
Interventions: Educational Intervention, Gabapentin, Pain Therapy, Quality-of-Life Assessment, Questionnaire Administration, Oxycodone/Acetaminophen, Hydrocodone/Acetaminophen, Fentanyl, Ibuprofen, Magic Mouthwash; Other · Drug
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Incisional Hernia, Ileostomy - Stoma
Interventions: duramesh, Control; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Gastrointestinal Disease, Gastrointestinal Dysfunction
Interventions: Biopsy imaged by Optical imaging device.; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obstructive Sleep Apnea, Hypertonia, Muscle, Nasal Airway Obstruction, Tolerance, Trisomy 21, Down Syndrome
Interventions: Self-Supporting Nasopharyngeal Airway (ssNPA); Device
Lead sponsor: University of Michigan; Other
Eligibility: 3 Years to 21 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Anal Fistula
Interventions: Surgery, Platelet-rich plasma (PRP), Matrix; Procedure · Other · Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acute Cellular Graft Rejection, New Onset Diabetes After Transplant
Interventions: Budesonide 3Mg Capsule, Standard of Care Prednisone; Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 21 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Crohn Disease
Interventions: Sample Collection; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 178 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Sunscreen Agents
Interventions: BAY 987519, SPF 15 Control; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Union, New Jersey

Conditions: Cancer
Interventions: One-on-one support/educational sessions, Telephone booster contact; Behavioral
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 484 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: Cleveland, Ohio

Conditions: Sexual Violence, Primary Prevention
Interventions: MKit; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Colon Cancer, IBS, Polyps
Interventions: Propofol, Fentanyl Plus Midazolam; Drug
Lead sponsor: Mount Carmel Health System; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Wound Infection and Wound Healing
Interventions: MyHealthPal App; Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chestnut Hill, Massachusetts

Conditions: Surgery, Immune System and Related Disorders, Preoperative Care, Gastrointestinal Disease, Urological Disease, Gynecologic Disease, Thoracic Diseases
Interventions: Physical Prehabilitation, Stress Reduction Prehabilitation, Cognitive Prehabilitation, Nutrition Prehabilitation; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Stanford, California

Conditions: Postoperative Pain, Opioid Use
Interventions: SZMN Block; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 6 Months to 18 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Spine Surgery
Interventions: Tranexamic Acid; Drug
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years to 80 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Albany, New York

Conditions: Eyelid Laceration
Interventions: Tissue Adhesive skin closure, Absorbable suture skin closure, Non-absorbable suture skin closure; Procedure
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cerebral Concussion
Interventions: ACTIVE Training; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 30 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Search by objective public record fields.

Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care

Community Activation for Prevention (CAPs): A Study of Community Gardening

Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer

Preventing Addiction Related Suicide (PARS)

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Effect of Duramesh™ on Hernia Formation After Ileostomy Closure

Optical Imaging of Gastrointestinal Biopsy Samples and Their Correlation With Histology

Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia

BIOlogic Augmented Repair of Complex Anal Fistula Using Acellular Matrix and/or Autologous Platelet-rich Plasma

Budesonide for Liver Transplant Immune Suppression

Combinatorial Single Cell Strategies for a Crohn's Disease Gut Cell Atlas

Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay

Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients

Testing a Life Skills Application to Address Interpersonal Relationships in College (MKit)

Patient Satisfaction With Propofol for Out Patient Colonoscopy

Post-Surgery Wound Healing Tracking With MyHealthPal App

Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery

SZMN Blocks for Pain Control in Pediatric Patients Undergoing T&A

Tranexamic Acid Infusion During Elective Spine Surgery

Cosmetic Outcome Study of Lid Laceration Repair With Suture Versus Tissue Adhesive

Acute Concussion Therapy Intervention Training in Healthy and Concussed Participants